Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 12, 2003

View Archived Issues

Company Profile: Transition Therapeutics

Genzyme to acquire SangStat

Akina develops oral drug delivery technology

Two novel series of VR1 antagonists for urinary incontinence, pain, etc.

Galderma presents new PPARgamma agonists with potential in dermatological disorders

BMS claims new IMPDH inhibitors and their use in recent patent

Aventis scientists prepare new antibacterial streptogramin derivatives

Novel alpha7 nAChR agonists in early development at Bayer

New MMP, TACE and/or aggrecanase inhibitors covered by BMS patent

R&D highlights at Neurosearch

Once-daily Adderall XR formulation may be a useful treatment option in children with ADHD

FTC clears Biogen/Idec merger

NexMed enters NexACT R&D agreement for asthma

Novel 5-HT7 receptor agonist modulates REM sleep

Human Genome Sciences and Genentech enter licensing agreement

17-AAG combination regimens studied in new phase Ib trials

Neurosciences Australia and CSIRO form R&D partnership in brain disorders

First pivotal exenatide study produces positive results

MPC-7869 reduces Abeta42 levels more effectively than select NSAIDs

Exelixis reports quarterly progress

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Gene therapies aim for the big goal of edits in vivo
BioWorld Science
The field of gene therapy is experiencing major advances driven by precise editing technologies, such as base and prime editing, and by the design of increasingly...